Live from the NIH registry
Studies recruiting near Santa Barbara right now
Top 25 of 99 recruiting studies, sorted by proximity — each links to its official registry page
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
FOMAT - West Coast Research Center — Ventura, California (26.5 mi)
· Sponsor: Duke University
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UCLA Hematology/Oncology - Santa Barbara — Santa Barbara, California (1.4 mi)
· Sponsor: Pfizer
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Sansum Diabetes Research Institute — Goleta, California (6.1 mi)
· Sponsor: Medtronic MiniMed, Inc.
Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
Parkinson Disease
EARLY/Phase 1
Interventional 50 participants sought
Equilibrium Physical Therapy — Ventura, California (26.5 mi)
· Sponsor: California State University, Northridge
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Cancer Center of Santa Barbara — Santa Barbara, California (1.4 mi)
· Sponsor: City of Hope Medical Center
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Advanced Cancer, Metastatic Cancer
Phase 1, Phase 2
Interventional 542 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Artios Pharma Ltd
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension
Phase 3
Interventional 344 participants sought
USA008 — Santa Barbara, California (1.4 mi)
· Sponsor: Insmed Incorporated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: NRG Oncology
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 272 participants sought
California Retina Consultants — Santa Barbara, California (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Aortic Stenosis, Coronary Artery Disease
N/A
Interventional 4,000 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: University of British Columbia
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Carey Chronis MD Pediatric, Infant and Adolescent Medicine — Ventura, California (26.5 mi)
· Sponsor: Eli Lilly and Company
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Multiple Myeloma
Phase 1
Interventional 134 participants sought
Sansum Clinic- Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: Oncotherapeutics
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Acute Myeloid Leukemia
Phase 3
Interventional 1,186 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: Children's Oncology Group
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
UCLA Montecito Primary & Specialty Care — Montecito, California (5.1 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer
Phase 1, Phase 2
Interventional 884 participants sought
USOR Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Genmab
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Janssen Research & Development, LLC
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 175 — Santa Barbara, California (1.4 mi)
· Sponsor: Adverum Biotechnologies, Inc.
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 840 participants sought
Research Site — Solvang, California (26.4 mi)
· Sponsor: AstraZeneca
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Santa Barbara, California (1.4 mi)
· Sponsor: DalCor Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Phase 2
Interventional 100 participants sought
California Retina Consultants- Santa Barbara — Santa Barbara, California (1.4 mi)
· Sponsor: Vantage Biosciences Ltd
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: Children's Oncology Group
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Aortic Stenosis, Calcific, Aortic Valve Stenosis
N/A
Interventional 2,250 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: Edwards Lifesciences
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: NRG Oncology
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group